We compared KRAS copy numbers in patients with early‐stage cancer and healthy individuals; surprisingly, DNA fragments captured by standard ddPCR in patients with PDA were not larger than those from healthy controls when normalized by plasma cfDNA concentrations. This evidence concerns the gene KRAS and cancer.